PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse
June 13, 2026American Journal of Law & MedicineOpen Access

Cutting Care: How Changes to the 340B Drug Pricing Program Impact Patients Served by Federally Qualified Health Centers

View Full Paper
Ask AI
Bookmark
Share

Authors

ASAlice Setrini

Discussion

Loading...

Member takes

Overview

The article discusses how changes to the 340B program affect medication access for low-income populations served by FQHCs, implying necessary reforms.

Key Points

  • This article examines the implications of changes to the 340B drug pricing program on Federally Qualified Health Centers and their patients.
  • Discusses the history and purpose of the 340B program and Medicaid drug pricing legislation.
  • Analyzes the impact of legal and proposed reforms on FQHCs' ability to fund health services.
  • Arguments for reinforcing discounting practices to support health care provision.
  • Changes to the 340B program threaten the financial sustainability of FQHCs.
  • Proposed reforms could limit access to essential medications for vulnerable populations.
  • Reinforcement of the existing discounting practices is necessary to maintain health services.

Cite This Study

Alice Setrini (2026) studied this question.

synapsesocial.com/papers/6a2cf551faef96ed7f05754fhttps://doi.org/10.1017/amj.2026.10097
View Full Paper
Ask AI
Bookmark
Share